Sona Mukete Franklin, Myung Seung-Kwon, Park Keeho, Jargalsaikhan Galsuren
Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea.
Regional Hospital Garoua, Ministry of Public Health, Garoua, Republic of Cameroon.
Jpn J Clin Oncol. 2018 May 1;48(5):426-433. doi: 10.1093/jjco/hyy047.
Previous observational studies have focused on the link between type 2 diabetes and the risk of cancer. However, the association between type 1 diabetes and the risk of cancer has not been well addressed. This study aimed to investigate the association between type 1 diabetes and the risk of cancer by using a meta-analysis of observational studies.
We searched PubMed and EMBASE for observational studies that examined the association between type 1 diabetes and cancer in April 2017. We calculated the pooled odds ratios (ORs) or relative risks (RRs) with confidence intervals (CIs) from individual studies based on a random-effects model meta-analysis.
We included a total of 15 observational studies with two case-control studies and 13 cohort studies involving 31 893 cancer patients among a total of 1 915 179 participants in the final analysis. In the random-effects meta-analysis of all studies, patients with type 1 diabetes had an increased risk of cancer (OR or RR, 1.29; 95% CI, 1.09-1.52; n = 15; I2 = 95.2%). In the subgroup meta-analysis by type of cancer, type 1 diabetes significantly increased the risk of cancers of stomach, lung, pancreas, liver, ovary and kidney, whereas it significantly decreased the risk of breast cancer (OR or RR, 0.91; 95% CI, 0.86-0.95; n = 9; I2 = 0%).
This meta-analysis suggests that type 1 diabetes is associated with the increased risk of several types of cancer and the decreased risk of breast cancer. However, the plausible mechanisms for the decreased risk of breast cancer remain unclear. Further prospective studies with proper adjustment for possible confounding factors are warranted.
既往观察性研究主要聚焦于2型糖尿病与癌症风险之间的联系。然而,1型糖尿病与癌症风险之间的关联尚未得到充分探讨。本研究旨在通过对观察性研究进行荟萃分析,调查1型糖尿病与癌症风险之间的关联。
我们于2017年4月在PubMed和EMBASE数据库中检索了探讨1型糖尿病与癌症之间关联的观察性研究。基于随机效应模型荟萃分析,我们计算了各研究的合并比值比(OR)或相对风险(RR)及其置信区间(CI)。
最终分析纳入了总共15项观察性研究,其中包括2项病例对照研究和13项队列研究,涉及1915179名参与者中的31893例癌症患者。在所有研究的随机效应荟萃分析中,1型糖尿病患者患癌症的风险增加(OR或RR为1.29;95%CI为1.09 - 1.52;n = 15;I² = 95.2%)。在按癌症类型进行的亚组荟萃分析中,1型糖尿病显著增加了胃癌、肺癌、胰腺癌、肝癌、卵巢癌和肾癌的发病风险,而显著降低了乳腺癌的发病风险(OR或RR为0.91;95%CI为0.86 - 0.95;n = 9;I² = 0%)。
本荟萃分析表明,1型糖尿病与多种癌症风险增加及乳腺癌风险降低相关。然而,乳腺癌风险降低的潜在机制仍不清楚。有必要开展进一步的前瞻性研究,并对可能的混杂因素进行适当调整。